anti-MNC2 antibody-drug conjugate (Minerva Biotechnologies)

N/A

Report date: 2025/06/11 11:18:44

Base Information

Drug Nameanti-MNC2 antibody-drug conjugate (Minerva Biotechnologies)
Drug Alias Nameanti-MNC2/exatecan antibody-drug conjugate (Minerva Biotechnologies)anti-MNC2/MMAE antibody-drug conjugate (Minerva Biotechnologies)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMinerva Biotechnologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesMinerva Biotechnologies Corp
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A